Latency Antibiotics

Antibiotics may be recommended during Expectant Management at appropriate gestational ages. These are often called latency antibiotics.

Their goals may include:

• reducing some infection-related complications

• decreasing the risk of certain neonatal infections

• helping prolong the time between membrane rupture and delivery

The antibiotic regimen and timing depend on gestational age and individual circumstances.

For very early PPROM, current professional guidance recommends antibiotics beginning at 24 weeks and allows that they may be considered between 20 and 23 weeks when Expectant Management is chosen.

Antenatal Corticosteroids

Antenatal corticosteroids are medications given before premature birth to help improve neonatal outcomes. They may reduce complications related to prematurity, including respiratory and neurologic complications.

The timing of corticosteroids depends on gestational age and how likely premature delivery is thought to be.

For previable and periviable PPROM, corticosteroids are generally recommended when neonatal resuscitation and intensive care would be considered appropriate and desired if delivery occurs.

Repeat or “Rescue” Courses

In some circumstances, a healthcare team may consider an additional course of corticosteroids when premature delivery remains likely.

Whether another course is appropriate depends on gestational age, timing of the first course, and the individual pregnancy.

Magnesium Sulfate

Magnesium sulfate may be given when very premature delivery is anticipated. In this setting, magnesium sulfate is used for fetal neuroprotection.

Its purpose is to reduce the risk of certain neurologic complications associated with very premature birth.

Magnesium sulfate is not given simply because PPROM has occurred. Timing depends on how likely delivery is and the gestational age.

Tocolysis

Tocolytics are medications that can temporarily reduce uterine contractions. They are not routinely used simply to prolong pregnancy after PPROM.

In selected circumstances, a healthcare team may consider short-term tocolysis, such as when additional time is needed to complete antenatal corticosteroids or arrange transfer to a hospital with a higher level of neonatal care.

Tocolysis is generally avoided when there are concerns such as infection, significant bleeding, fetal compromise, or other reasons that delivery may be safer.

Cerclage After PPROM

Some patients experience PPROM while a cervical cerclage is still in place. There is not one management approach that is appropriate for every patient.

Depending on the clinical situation, the healthcare team may discuss either:

• removing the cerclage, or

• leaving it in place for a period of time

Current guidance supports individualized counseling and shared decision-making.

Amnioinfusion, Amniopatch & Membrane Repair

Researchers have studied techniques intended to replace amniotic fluid or seal an opening in the fetal membranes.

These approaches include:

• serial amnioinfusion

• amniopatch procedures

• bioadhesives and other fetal membrane repair technologies

These treatments remain investigational.

Current professional guidance does not recommend serial amnioinfusion or amniopatch as routine treatment for previable or periviable PPROM outside of clinical research.

Research into fetal membrane healing and repair is ongoing.

Learn more in the PPROM Library

Progesterone

Progesterone has been studied extensively for the prevention of spontaneous preterm birth. Progesterone is not a treatment for an established PPROM pregnancy.

Older studies investigated whether progesterone could prolong pregnancy after membranes had already ruptured, but it has not become a standard treatment for PPROM.

Progesterone may still be discussed in a future pregnancy, particularly when there is a history of spontaneous preterm birth or a short cervix.

Recommendations have changed significantly in recent years. The injectable medication 17-hydroxyprogesterone caproate (17-OHPC/Makena) is no longer FDA-approved for prevention of recurrent preterm birth.

Vaginal progesterone may be considered in some pregnancies with a short cervix. Patients with a previous PPROM pregnancy should discuss recurrence prevention and cervical-length monitoring with their obstetric provider or Maternal-Fetal Medicine specialist.

Delivery

Sometimes the safest intervention after PPROM is delivery.

Reasons delivery may be recommended can include:

• infection or serious concern for infection

• placental abruption or significant bleeding

• fetal compromise

• labor that cannot or should not be stopped

• umbilical cord complications

• other maternal or fetal concerns

• reaching a gestational age when planned delivery is recommended

The decision depends on the circumstances of the individual pregnancy.

Understanding Treatment Decisions

It is appropriate to ask your healthcare team:

• What is this treatment intended to do?

• What evidence supports it?

• What are the benefits and risks?

• Why is it being recommended now?

• Would the recommendation change at another gestational age?

• What would make you recommend delivery instead of continuing Expectant Management?

• Is this treatment standard care or experimental?

PPROM treatment decisions can change as the pregnancy progresses.

Research & Current Guidance

Current Professional Guidance

Society for Maternal-Fetal Medicine Consult Series #71: Management of Previable and Periviable Preterm Prelabor Rupture of Membranes

SMFM, 2024. Endorsed by ACOG.

Current professional guidance addressing antibiotics, antenatal corticosteroids, magnesium sulfate, cerclage, Expectant Management, and investigational treatments following very early PPROM.

Read SMFM Consult Series #71

Corticosteroids

ACOG & SMFM Practice Advisory: Use of Antenatal Corticosteroids at 22 Weeks of Gestation

Professional guidance addressing corticosteroid administration when neonatal resuscitation is planned at very early gestational ages.

Read the ACOG Practice Advisory

Magnesium Sulfate

Magnesium Sulfate Before Anticipated Preterm Birth for Neuroprotection

Professional guidance regarding magnesium sulfate for fetal neuroprotection when early preterm delivery is anticipated.

Read ACOG Guidance

Progesterone & Future Pregnancy

SMFM Statement: Response to the FDA Withdrawal of 17-OHPC

Current professional guidance following withdrawal of FDA approval for 17-hydroxyprogesterone caproate.

Read the SMFM Statement

Emerging Fetal Membrane Repair

Biomaterials for Fetal Membrane Repair in Preterm Premature Rupture of Membranes: Advances in Tissue Engineering Strategies

Fan L, et al. 2025.

A review of experimental approaches including hydrogels, bioadhesives, scaffolds, and other technologies being studied for fetal membrane repair.

Read the Full Study

Information reviewed: August 2026